The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Superparamagnetic Iron Oxide Nanoparticles: Diagnostic Magnetic Resonance Imaging and Potential Therapeutic Applications in Neurooncology and Central Nervous System Inflammatory Pathologies, a Review
Open accessAbstract
Superparamagnetic iron oxide nanoparticles have diverse diagnostic and potential therapeutic applications in the central nervous system (CNS). They are useful as magnetic resonance imaging (MRI) contrast agents to evaluate: areas of blood-brain barrier (BBB) dysfunction related to tumors and other neuroinflammatory pathologies, the cerebrovasculature using perfusion-weighted MRI sequences, and in vivo cellular tracking in CNS disease or injury. Novel, targeted, nanoparticle synthesis strategies will allow for a rapidly expanding range of applications in patients with brain tumors, cerebral ischemia or stroke, carotid atherosclerosis, multiple sclerosis, traumatic brain injury, and epilepsy. These strategies may ultimately improve disease detection, therapeutic monitoring, and treatment efficacy especially in the context of antiangiogenic chemotherapy and antiinflammatory medications. The purpose of this review is to outline the current status of superparamagnetic iron oxide nanoparticles in the context of biomedical nanotechnology as they apply to diagnostic MRI and potential therapeutic applications in neurooncology and other CNS inflammatory conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Many iron oxide nanoparticles have been evaluated in preclinical and clinical trials, and several of them have reached the market (Table 1) [4, 22–26].”
From Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications (2019) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Laurent, S., Forge, D., Port, M., Roch, A., Robic, C., Vander Elst, L., & Muller, R. N. (2008) · Chemical Reviews · doi:10.1021/cr068445e · Cited by 6,852
Response criteria for phase II studies of supratentorial malignant glioma.
Macdonald, D. R., Cascino, T. L., Schold, S. C., & Cairncross, J. G. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.7.1277 · Cited by 2,409
Rohrer, M., Bauer, H., Mintorovitch, J., Requardt, M., & Weinmann, H. (2005) · Investigative Radiology · doi:10.1097/01.rli.0000184756.66360.d3 · Cited by 1,681
Recent advances in iron oxide nanocrystal technology for medical imaging☆
Corot, C., Robert, P., Idée, J., & Port, M. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.013 · Cited by 1,461
Perfusion imaging with NMR contrast agents
Rosen, B. R., Belliveau, J. W., Vevea, J. M., & Brady, T. J. (1990) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910140211 · Cited by 1,141
Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
Brandsma, D., Stalpers, L. J. A., Taal, W., Sminia, P., & van den Bent, M. J. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70125-6 · Cited by 1,120
Weissleder, R., Elizondo, G., WITTENBERG, J., Rabito, C. A., Bengele, H. H., & Josephson, L. (1990) · Radiology · doi:10.1148/radiology.175.2.2326474 · Cited by 1,027
Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings.
Aronen, H. J., Gazit, I. E., Louis, D. N., Buchbinder, B. R., Pardo, F. S., Weisskoff, R. M., Harsh, G. R., Cosgrove, G. R., Halpern, E. F., & Hochberg, F. H. (1994) · Radiology · doi:10.1148/radiology.191.1.8134596 · Cited by 905
Chertok, B., Moffat, B. A., David, A. E., Yu, F., Bergemann, C., Ross, B. D., & Yang, V. C.-M. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.08.050 · Cited by 901
Flagged first, then by citations
Research works printed but not linked: 15
- Barnett PA, 1995, Am J Pathol, 146, 436
- Cameron DG, 1951, Can Med Assoc J, 64, 27
- Chang KH, 1994, AJNR Am J Neuroradiol, 15, 1413
- Dousset V, 2006, AJNR Am J Neuroradiol, 27, 1000
- Hunt MA, 2005, AJNR Am J Neuroradiol, 26, 1084
- Kraemer DF, 2001, Neurosurgery, 48, 1033
- Kremer S, 2002, J Neuroradiol, 29, 105
- Lev MH, 2004, AJNR Am J Neuroradiol, 25, 214
- Manninger SP, 2005, AJNR Am J Neuroradiol, 26, 2290
- Miki Y, 1997, AJNR Am J Neuroradiol, 18, 705
- Moseley ME, 1990, AJNR Am J Neuroradiol, 11, 423
- Muldoon LL, 2006, AJNR Am J Neuroradiol, 27, 715
- Soroceanu L, 1998, Cancer Res, 58, 4871
- Varallyay P, 2002, AJNR Am J Neuroradiol, 23, 510
- Yuh WT, 1991, AJNR Am J Neuroradiol, 12, 621
Cited by
Sorted by citations
Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications
Dadfar, S. M., Roemhild, K., Drude, N. I., von Stillfried, S., Knüchel, R., Kiessling, F., & Lammers, T. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.01.005 · Cited by 1,181
Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers
Wahajuddin, M., & Arora, S. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s30320 · Cited by 1,148
Therapeutic efficacy of nanoparticles and routes of administration
Chenthamara, D., Sadhasivam, S., Ramakrishnan, S. G., Krishnaswamy, S., Essa, M. M., Lin, F., & Qoronfleh, M. W. (2019) · Biomaterials Research · doi:10.1186/s40824-019-0166-x · Cited by 1,103
Engaging neuroscience to advance translational research in brain barrier biology
Neuwelt, E. A., Bauer, B., Fahlke, C. M., Fricker, G., Iadecola, C., Janigro, D., Leybaert, L., Molnár, Z., O’Donnell, M. E., Povlishock, J. T., et al. (2011) · Nature reviews. Neuroscience · doi:10.1038/nrn2995 · Cited by 594
Self-citationExceedingly small iron oxide nanoparticles as positive MRI contrast agents
Wei, H., Bruns†, O. T., Kaul, M. G., Hansen, E. C., Barch, M., Wiśniowska, A. E., Chen, O., Chen, Y., Li, N., Okada, S., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620145114 · Cited by 500
Metadata
- Authors
- Weinstein, J. S., Varallyay, C. G., Dosa, E., Gahramanov, S., Hamilton, B., Rooney, W. D., Muldoon, L. L., & Neuwelt, E. A.
- Affiliations
- Oregon Health & Science University (US)
- Department of Neurology, Oregon Health and Science University, Portland, Oregon, USA
- Corresponding author
- Neuwelt, Edward A
- Venue
- Journal of Cerebral Blood Flow & Metabolism
- Publisher
- SAGE Publications
- Published
- 2009-09-16
- Volume
- 30
- Issue
- 1
- Pages
- 15-35
- ISSN
- 0271-678X (ISSN-L)
- 1559-7016
- PMC
- PMC2949106
- OpenAlex
- W2059756358
- Cited by
- 500
- References
- 126
- Citations by year
- 2026: 12 · 2025: 15 · 2024: 21 · 2023: 24 · 2022: 21 · 2021: 20 · 2020: 18 · 2019: 32 · 2018: 41 · 2017: 37 · 2016: 33 · 2015: 41 · 2014: 41 · 2013: 51 · 2012: 41
- FWCI
- 2.66
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Cerebral Blood Flow & Metabolism (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS 33618, R01NS053468, NS053468, R37NS044687, NS34608, R01NS033618, R01NS044687, R01NS034608, NS-44687)
- National Institute of Biomedical Imaging and Bioengineering (R01EB007258)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Characterization and Applications of Magnetic Nanoparticles
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- superparamagnetic iron oxide nanoparticles, MRI contrast agents, neuro-oncology, brain tumors, blood-brain barrier dysfunction, neuroinflammation, perfusion-weighted MRI, cerebrovascular imaging, cell tracking, cerebral ischemia, stroke, carotid atherosclerosis, multiple sclerosis, traumatic brain injury, epilepsy, anti-inflammatory therapy, nanomedicine
- MeSH terms
- Animals, Blood-Brain Barrier, Contrast Media, Electron Spin Resonance Spectroscopy, Ferric Compounds, Humans, Inflammation, Magnetic Resonance Imaging, Particle Size, Central Nervous System Neoplasms, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
